New sites at Darmstadt and Hamburg complement company’s global integrated mRNA service network with pre-clinical to commercial capabilities Company’s Millipore® CTDMO Services now encompass all key stages of mRNA technologies, lipids, lipid nanoparticles (LNP) and fill/finish, including key products and biosafety testing Expansion part of company’s ongoing € 1 billion investment plan to advance mRNA technologies […]

Menlo Park – Pacific Biosciences of California, Inc., a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings. Although the jury sided with Pacific Biosciences […]

Partnership to accelerate the adoption of next-generation sequencing (NGS) in clinical decision-making SAN DIEGO & HILDEN, Germany & GERMANTOWN, Md.–Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the availability and use of NGS-based IVD kits, including companion diagnostics, for patient management. The […]

BOSTON– NanoView Biosciences, Inc., and Alfatest today announced an exclusive distribution agreement for NanoView’s ExoViewâ„¢ platform in Italy. “We believe that scientists in Italy will be excited to have access to NanoView’s unique exosome characterization technology to open up new avenues of research into extracellular vesicles,” said Valentino Polchi, General Manager of Alfatest. “Our team […]

STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”) (“we,” “us,” “our,” the “Company”), a leader in large-scale PCR-based DNA manufacturing, today announced  that the Nasdaq Hearings Panel (the “Panel”) , has granted Applied DNA’s request for an extension through December 31, 2019, to comply with all applicable criteria for continued listing of the Company’s […]

PROVIDENCE RI Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation. Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Mappingâ„¢ whole-genome electronic mapping platform. HD-Mapping has applications in a wide variety of […]

SAN JOSE, Calif. – Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California. The lawsuit, filed September 30, alleges that Illumina and its customers are using various gene sequencers and related reagents, including NovaSeq 6000, HiSeq X Ten, HiSeq 3000, and HiSeq 4000, […]

ATCC Genome Portal Provides Access to Reference-quality Genomes, Enabling Increased Confidence in Research Manassas, VA – ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence. The portal, which launched with an initial 250 genome […]

SAN DIEGO — Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures. The proceeds of the financing will be used to advance the company’s proprietary enzymatic DNA synthesis technology to power DNA-based products […]

HSINCHU, Taiwan – Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a complaint in the U.S. District Court for the District of Delawareagainst Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the […]